Tag: Pharmaceuticals
SRP in brief: allez, allez, allez
Europe | Industry
28 Oct 2024 by SRP News
Interest linked structured products came out on top in the French market during the first nine months of 2024, according to SRP research.
Product wrap: Goldman puts luxury goods, pharmaceuticals in focus
International | Products
25 Oct 2024 by Marc Wolterink
In this week’s wrap we look at a selection of structured products with strike dates between 20-26 October 2024.
Product snapshot: RCB offers 10% coupon on US vaccine basket
International | Products
20 Apr 2021 by Marc Wolterink
The Austrian structured product house has launched a reverse convertible on a worst of basket of three pharma stocks.
Pharma in structured products (part 3) – performance and underlying analysis
International | Products
24 Mar 2021 by Filip Dyankov
In the third part of our analysis, we look at the markets that saw the best performance for pharma products during 2020 as well as modern portfolio theory (MPT) considerations and its deficiencies when applied to the structured product ecosystem.
Pharma in structured products (part 2) - stagnating issuance in main pharma markets
International | Products
23 Mar 2021 by Filip Dyankov
Buoyant issuance in Malaysia, Belgium and France; reverse convertibles linked to pharma companies have been less affected than growth products, notably the leverage long with stop loss; US breakdown – CVS Health losing ground in sales, Merck records sustained growth.
Pharma in structured products - issuance & sales
International | Products
22 Mar 2021 by Filip Dyankov
Underlying analysis of pharma-based structured products amid a challenging economic climate shows falling sales and issuance.
